What do systematic reviews say?

Any frequency of application of a topical skin care product vs another frequency of application of the topical skin care product

The review found no eligible studies for this question.

• Interventions for preventing and treating incontinence‐associated dermatitis in adults 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The intervention showed no clear difference in alcohol‐related problems: 4+ months—individual face‐to‐face… (moderate certainty).

• Social norms information for alcohol misuse in university and college students 2015 · Cochrane Headline outcomes only
  no estimate extracted
  11 studies · 2327 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in frequency: 4+ months—individual face‐to‐face normative feedback (moderate certainty).

• Social norms information for alcohol misuse in university and college students 2015 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 1464 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in typical BAC: 4+ months—individual face‐to‐face normative feedback (moderate certainty).

• Social norms information for alcohol misuse in university and college students 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 490 participants
  Moderate

Home‐based vs clinic‐based specimen collection

• Home‐based versus clinic‐based specimen collection in the management of Chlamydia trachomatis and Neisseria… 2015 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 10479 participants
  Low

Surgical anchorage (mini-screw or mid-palatal implant) vs Conventional anchorage (headgear, transpalatal/palatal arch, etc.)

The review found no eligible studies for this question.

• Reinforcement of anchorage during orthodontic brace treatment with implants or other surgical methods 2014 · Cochrane All outcomes
  No studies reported on residual overjet at the end of treatment
  0 studies
  No studies found

Intervention not reported

It is very uncertain whether the intervention changes response rate at post‐treatment (as defined in individual studies) (very low certainty).

• Antidepressant treatment for postnatal depression 2014 · Cochrane Headline outcomes only
  RR 1.43 [1.01, 2.03]
  3 studies · 146 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes remission rate at post‐treatment (as defined in individual studies) (very low certainty).

• Antidepressant treatment for postnatal depression 2014 · Cochrane Headline outcomes only
  RR 1.79 [1.08, 2.98]
  3 studies · 146 participants
  Very low

Intervention not reported

The intervention probably leads to higher individual counselling (moderate certainty).

• Workplace interventions for smoking cessation 2014 · Cochrane Headline outcomes only
  OR 1.96 [1.51, 2.54]
  8 studies · 3516 participants
  Moderate

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 40 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 21 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 21 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 21 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 22 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 19 participants
  Very low

PRO 140 vs placebo

• Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 19 participants
  Very low

Imiquimod 5% cream with tazarotene 0.1% gel vs Imiquimod 5% cream alone

Imiquimod 5% cream with tazarotene 0.1% gel showed no clear difference in primary outcome: Histological complete response (intention‐to‐treat)… compared with imiquimod 5% cream alone (low certainty).

• Interventions for melanoma in situ, including lentigo maligna 2014 · Cochrane Headline outcomes only
  RR 1.12 [0.81, 1.55]
  1 study · 90 participants
  Low
• Interventions for melanoma in situ, including lentigo maligna 2014 · Cochrane Headline outcomes only
  RR 1.19 [0.9, 1.57]
  1 study · 78 participants
  Low

Alcohol ban vs no ban

The review found no eligible studies for this question.

• Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Non‐alcohol commercials vs alcohol commercials

The review found no eligible studies for this question.

• Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Cognitive rehabilitation vs control

• Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia 2013 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 39 participants
  High